1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. AMGEN INC.
AMGEN Inc. XNAS: AMGN

AMGEN Inc. Live Share Price Today, Share Analysis and Chart

Mid-range Performer
about

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first ...

Read More
289.33 -0.30 (-0.10%)
6.7M
XNAS Volume
High volume today

XNAS 20 Jun, 2025 4:11 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for AMGEN Inc. is on 23 Jun 2025 for the purpose of Amgen Conference Call from ADA 2025 See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
39.2 / 100
Momentum Score
Technically Neutral
51.8 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
315
1Yr Price target upside is 9%
28 analysts

4

S

14

W

0

O

2

T

SWOT Analysis

AMGEN Inc. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

AMGEN Inc. FAQ

How is AMGEN Inc. today?
AMGEN Inc. today is trading in the red, and is down by -0.10% at 289.33.
AMGEN Inc. is currently trading down -0.10% on an intraday basis. In the past week the stock fell -2.00%. stock has been down -8.45% in the past quarter and fell -6.11% in the past year. You can view this in the overview section.